Per our UNMC #2005 Waste Handling Policy these items are defined as biohazardous waste no matter how they are used. All pipettes and pipette tips must be disposed as biohazard waste even if they are autoclaved. For convenience we have allowed used pipettes and pipette tips to be collected in boxes for disposal lined with plastic bags. When ready for disposal the bag should be twisted closed and tied in a single knot (liquid tight), the box closed and placed in a biohazardous waste container for disposal. This process will protect those that must handle these items through the disposal process.
USEFUL LINKS TO INFORMATION ON THIS TOPIC:
Information on biohazardous waste at: http://info.unmc.edu/safety/safety-office/biohazardous-waste/index.html
Educational handout: http://info.unmc.edu/safety/safety-office/biohazardous-waste/sharps_biowaste_info_OCT2012.pdf
UNMC #2005 Waste Handling Policy: http://wiki.unmc.edu/Waste_Handling
Let me know if you have any questions
John M. Hauser
University of Nebraska Medical Center
987150 Nebraska Medical Center
Omaha, NE 98198-7150
As the Spring grant deadlines are rolling in please remember that grants are due to Sponsored Programs at least three business days before the sponsor’s deadline. The complete policy statement is included below:
Complete research proposals are due to Sponsored Programs Administration (SPA) at least three business days before the sponsor’s deadline. This will allow adequate time for SPA review of grant and contract requirements and for the completion of the electronic submission process. SPA will review budget with a draft of abstract, as soon as they are available. Applications submitted less than 3 days prior to the sponsor’s deadline are not guaranteed to be submitted by the required deadline and will not be prioritized over those submitted in a timely fashion.
Please Post and Circulate
NIH / AHRQ Release Date: April 17, 2014
Distributed: April 21, 2014
Effective immediately for all investigators, the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ) will accept a new (A0) application following an unsuccessful resubmission (A1) application.
The subsequent A0 application:
- Need not demonstrate substantial changes in scientific direction compared to the A1
- Must not contain a respond to the previous reviewers’ comments (“Introduction”)
In 2009, the NIH changed its policy to allow only one resubmission (A1), with the goal of reducing the time from original submission to funded application. The NIH reports that after this change, the number of applicants funded after only A0 submissions increased. However, investigators also voiced concerns about having to take one’s research in a new direction in order to continue to submit applications.
The following policies remain in effect:
- The NIH will not accept duplicate or highly overlapping applications under review at the same time
- An A1 application must be submitted within 37 months of the A0 application
- New Investigators may submit A1 applications for consecutive review cycles, using the New Investigator resubmission due dates (April 10, August 10, or December 10)
For more information